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with stage IV metastatic non-small cell lung cancers. All patients have 
been prospectively registered with clinical TNM staging. Patients were 
found with N0-1 and N2-3 status in 34% and 66%, respectively. Two 
hundred and twenty patients (56%) were classiﬁed T1-2, while 172 
were found T3-4 (44%). Interestingly 13% of the patients were found 
T1-2N0. 
Conclusion: T and N descriptors by themselves seem to be bad predic-
tors of metastatatic disease in non-small cell lung cancer. 
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Objectives: The purpose of our study was to compare the diagnostic 
efﬁcacies of helical dynamic CT and integrated PET/CT for the predic-
tion of mediastinal nodal metastasis in stage below IIIB non-small cell 
lung cancer (NSCLC). 
Patient and Methods: Sixty one patients (M: F = 48:13, age range 
41-79 ) with NSCLC underwent lobectomy or pneumonectomy 
were included. In enhanced CT, the diagntostic criteria of metastatic 
mediastinal nodes were over 10mm (measured by short axis) lymph 
node without deﬁnite calciﬁcations. In integrated PET/CT, nodes were 
regarded as positive for malignancy when they showed over 2.5 ( in 1 
hr) in maximum standardized uptake value with a discrete margin and 
more 18F-FDG uptake than mediastinal structures. And the retention 
index was acquired by this equation RI (Retention Index) = (SUV 
1h-SUV2h)x100/SUV 1h Sensitivities, speciﬁcities, and accuracies for 
mediastinal nodal metastasis detection were compared with enhanced 
CT and integrated PET/CT, histopathologic results. 
Results: Of the 61 patients, 23 (37%) had positive mediastinal nodes. 
The sensitivity, speciﬁcity for mediastinal nodal metastasis prediction 
on enhanced CT by size criteria alone were 72%, 69%, respectively, 
whereas those on integrated PET/CT were 92 %, 97% by determined 
the initial SUV and retention index.
Conclusions: In NSCLC (operable cases, staege, I, II IIIA), preopera-
tive nodal staging by contrast enhanced CT scan, but mediastinal nodal 
metastasis than PET/CT, whereas PET/CT shows excellent speciﬁcity 
and sensitivities
P1-065 Imaging and Staging Posters, Mon, Sept 3 
Prognostic significance of thin-section CT findings in small-sized 
lung adenocarcinoma
Hashizume, Toshihiko; Yamada, Kouzo; Okamoto, Naoyuki; Saito, 
Haruhiro; Oshita, Fumihiro; Kato, Yasufumi; Ito, Hiroyuki; Nakayama, 
Haruhiko; Kameda, Youichi; Noda, Kazumasa 
Kanagawa Cancer Center, Yokohama, Japan
Background: The purpose of this study is to evaluate the prognostic 
importance of thin-section CT (TS-CT) ﬁndings in small-sized lung 
adenocarcinomas. 
Methods: We reviewed TS-CT ﬁndings and pathological specimens 
from 359 consecutive patients who underwent surgical resection for 
peripheral lung adenocarcinomas smaller than 20 mm in diameter dur-
ing the period from July 1997 to May 2006. By using TS-CT images, 
tumors were deﬁned as air-containing types if the maximum diameter 
of tumor opacity on mediastinal window images was less than or equal 
to half of that on lung window images, and as a solid-density type if 
the maximum diameter on mediastinal window images was more than 
half of that on lung window images. We compared TS-CT ﬁndings to 
pathological ﬁndings (lymph node metastasis, pleural invasion, vessel 
invasion, and lymphatic permeation) and prognosis. The following 
prognostic factors were analyzed by chi-square test and Cox propor-
tional hazard model: age, gender, tumor size, pathological stage, TS-CT 
ﬁndings, histologic subtypes deﬁned by Noguchi (Noguchi type), pleu-
ral involvement, lymphatic permeation, and vascular invasion. 
Results: No pathological invasive ﬁndings or recurrence were found in 
patients with air-containing type tumors. Pathological invasive ﬁndings 
and recurrence were found in 10% to 30% of patients with solid-den-
sity type tumors. The air-containing type on TS-CT and Noguchi type 
A or B were demonstrated as prognostic factors for good outcome by 
chi-square test (p<0.001). Multivariate analyses revealed lymphatic 
permeation as a signiﬁcant prognostic factor. 
Conclusions: The TS-CT ﬁndings were important predictive factors for 
postsurgical outcome in patients with lung adenocarcinoma.
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Background: Pulmonary imaging with hyperpolarized helium-3 (3He-
MRI) is emerging as an alternative to SPECT that has the potential to 
provide superior lung function information. In particular, ventilation 
and perfusion data from 3He-MRI may be used for functionally weight-
ed intensity modulated radiotherapy (IMRT) lung planning [1]. The 
aim of this study was to develop and evaluate an improved protocol for 
image registration of 3He-MRI to treatment planning x-ray CT.
Methods: An initial six NSCLC patients underwent 3He-MRI with a 
radiofrequency coil that required the patients to be imaged supine with 
their arms down, and a free breathing single-slice CT protocol for treat-
ment planning. The 3He gas was polarized on site to 30% and imaging 
was performed during a single 14s breath-hold of a 300ml 3He/700ml 
N2 mixture. Following the development of an elliptical birdcage 3He-
MRI coil [2] and the installation of a 16-slice CT, a further six patients 
were scanned. A new protocol was devised that enabled 3He-MRI to be 
acquired in treatment position and a planning CT to be acquired during 
an inspiration breath-hold performed with a 1L bag ﬁlled with room air 
that simulated the 3He-MRI breathing maneuver. For all images, 3He-
MRI to CT image fusion was performed using anatomical landmark 
based rigid registration which was assessed using the relative volume 
overlap [1]. 
Results: Over all slices, the original 3He-MRI and CT were regis-
tered with (mean±SD) overlap 73±11%. With the new equipment and 
modiﬁed imaging protocol, the overlap was signiﬁcantly improved to 
84±4% (p=0.05). 
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Conclusions: Statistically signiﬁcant improvements to 3He-MRI to 
planning CT image registration can be achieved by using a dedicated 
imaging protocol that enables both 3He-MRI and planning CT to be 
acquired with similar breath holds and body position. Improved image 
registration accuracy will be beneﬁcial when performing functionally-
weighted IMRT planning.
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Background: We have previously reported that tumor opacity in 
the mediastinal window image in thin-section CT (TS-CT) is associ-
ated with prognosis of lung adenocarcinoma of 20 mm or smaller in 
diameter. However, pathological investigation of the tumor opacity in 
the mediastinal window has not been performed in detail. To investi-
gate the relationship between imaging and pathological ﬁndings, the 
solid lesion in the pathological preparation observed under a magnify-
ing glass (SLP) and tumor opacity in the mediastinal window image 
(TOM) in TS-CT were compared. The relationships of SLP and TOM 
with relapse were also investigated. 
Methods: The subjects were 115 patients with a lung adenocarcinoma 
of 20 mm or smaller in diameter who underwent surgical resection at 
the Kanagawa Cancer Center between January 1997 and October 2003. 
Pathological and imaging ﬁndings for these patients were re-investigat-
ed in this study. Patients with bronchioloalveolar carcinoma (BAC) that 
was undetectable in the mediastinal window image were excluded. SLP 
was deﬁned as follows: 1) regions with alveolar collapse, 2) regions 
accompanied by destruction of the alveolar framework, and 3) regions 
described in 2) accompanied by collagen ﬁbrotic foci. The maximum 
diameters of the tumor and SLP were measured in the pathological 
preparation, and the proportion of the maximum diameter of the SLP to 
the maximum tumor diameter was calculated as the pathological ratio. 
In TS-CT, the proportion of the reduction in the TOM maximum diam-
eter to the maximum diameter of the tumor opacity in the lung window 
was calculated as the reduction percentage. Correlations between the 
maximum SLP and TOM diameters and between the pathological ratio 
and the reduction percentage were investigated, and the association of 
relapse with SLP, TOM, the pathological ratio, and reduction percent-
age was also examined. 
Results: Strong Pearson correlations were noted between the maximum 
TOM and SLP diameters (correlation coefﬁcient: 0.852, p<0.0001) and 
between the reduction percentage and pathological ratio (correlation 
coefﬁcient: 0.895, p<0.0001). The maximum TOM and SLP diameters 
were not signiﬁcantly associated with relapse. However, the incidence 
of relapse was signiﬁcantly higher in patients with a reduction percent-
age of less than 50% by log-rank test; no relapse occurred in patients 
with a reduction percentage of 50% or higher. Similarly, the incidence 
of relapse was signiﬁcantly higher in patients with a pathological ratio 
of less than 50% by log-rank test; no relapse occurred in patients with a 
pathological ratio of 50% or higher in the pathological preparation. 
Conclusions: Use of the reduction percentage in TS-CT to classify 
lesions into two groups with different prognoses is valid based on the 
pathological investigation. Therefore, measurement of the reduction 
percentage and pathological ratio may allow prediction of cases of 
small adenocarcinoma of the lung with a good prognosis.
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Background: Response evaluation criteria in solid tumor (RECIST) is 
widely used as a standard method for evaluation of tumor response in 
clinical oncology. RECIST is based on uni-dimensional measurement 
of target lesions and is simpler than WHO criteria which are based on 
bi-dimensional measurement. In clinical practice, we sometimes use 
serum tumor markers to estimate tumor response as well, particularly 
when measurement of tumor size is difﬁcult. The aim of this study is to 
compare WHO criteria, RECIST, and serum carcinoembryonic antigen 
(CEA) level for evaluating tumor response to chemotherapy in non-
small cell lung cancer (NSCLC).
Patients and Methods: During an 11-year period from 1995 through 
2005, 24 NSCLC patients with high serum CEA level (> 5ng/ml) at 
presentation were retrospectively analyzed. They underwent pulmonary 
resection after induction chemotherapy. In each case, we compared 
histological response of tumor response of resected specimens.
Results: Using WHO criteria, nine and 15 patients achieved partial re-
sponse (PR) and no change (NC), respectively. With RECIST, PR was 
seen in 11 patients, stable disease (SD) in 13. Concordance between 
WHO and RECIST was 83 %. When we compare CEA level before 
chemotherapy with that obtained after chemotherapy, CEA levels 
signiﬁcantly decreased in PR group deﬁned by WHO criteria [26.3 
(median) ng/ml to 4.3 ng/ml, P = 0.008, wilcoxon t test] or RECIST 
[17.3 ng/ml to 4.4 ng/ml, P = 0.004, wilcoxon t test ]. On the contrary, 
in patients whose responses were NC or SD, there was no signiﬁcant 
difference [16.8 ng/ml to 9.9 ng/ml, P = 0.24, 16.8ng/ml to 19.6 ng/ml, 
P = 0.24, respectively]. In comparison of CEA level with histologic re-
sponse, CEA decreased signiﬁcantly in patients in whom less than one-
third of tumor cells were viable [17.3 ng/ml to 4.4 ng/ml, P = 0.008, 
wilcoxon t test] but not in whom more than two thirds of tumor cells 
were viable [16.8 ng/ml to 7.9 ng/ml, P = 0.06, wilcoxon t test]. From 
